Clinical Trials Search Results

Results 11-20 of 116 for your search
Show Search Criteria
Safety, Tolerability and Pharmacokinetics of an Anti-PD-1 Monoclonal Antibody in Subjects With Advanced Malignancies
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 9 locations
CPI-006 Alone and in Combination With CPI-444 and With Pembrolizumab for Patients With Advanced Cancers
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 10 locations
First-in-human Study of ATR Inhibitor BAY1895344 in Patients With Advanced Solid Tumors and Lymphomas
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 10 locations
Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158 / KEYNOTE-158)
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 9 locations
Nivolumab in Treating Patients with Metastatic or Recurrent Uterine Cancer
Status: Active
Age: 18 years and over
Gender: Female
Location: 7 locations
Durvalumab with or without Tremelimumab in Treating Patients with Recurrent or Persistent Endometrial Cancer
Status: Active
Age: 18 years and over
Gender: Female
Location: 7 locations